After surgery, women diagnosed with early-stage, hormone-receptor-positive breast cancer usually take hormonal therapy medicine to reduce the risk of the cancer coming back recurrence. So the benefits of taking tamoxifen for 10 years have to be weighed against 10 years of possible side effects. Your email only if you want to be breast cancer return rates back. National Comprehensive Cancer Network.
Hi! My name is Kerri. I have 32 years old. I love big cock. My favorit is Shower, Clitoris, Orgy, Latina porn
Someone has sent you a privat video :)
Breast cancer recurrence risk lingers years after treatment ends
This content does not have an Arabic version. Your opinions are important to us. Hormone-receptor-positive breast cancer can come back, and hormonal therapy after surgery reduces that risk -- you must remember that.
We know that treatments have improved since then, so recurrence rates will be somewhat lower for women who were diagnosed more recently," he says. Although the initial treatment is aimed at eliminating all cancer cells, a few may have evaded treatment and survived. The researchers then used statistical breast cancer return rates to see if there were links between the characteristics of the cancer and the rates of distant recurrence. The data suggest that women with ER-positive breast cancer should at least consider taking anti-estrogen therapy beyond five years, the authors say.